Apogee Enterprises vs Quanex Building Products
APOG and NX side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How APOG and NX compare
Apogee Enterprises and Quanex Building Products are about the same size, with market caps of $986M and $879M.
On earnings, Apogee Enterprises is cheaper: it trades at 14.9× trailing earnings, against 19.4× for Quanex Building Products.
Apogee Enterprises grew revenue faster over the last twelve months (3.0% versus 1.3% for Quanex Building Products).
Apogee Enterprises keeps more of each dollar of sales as profit, with a net margin of 4.7% compared with 2.4% at Quanex Building Products.
Both pay dividends: Apogee Enterprises yields 2.3% and Quanex Building Products 1.7%.
Apogee Enterprises scores higher on the StockData Score (17 against 12 for Quanex Building Products), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | APOG | NX |
|---|---|---|
| Size and price | ||
| Market cap | $986M | $879M |
| Share price | $47.17 | $19.19 |
| Change, 1 year | 36.7% | 45.6% |
| Change, 5 years | 1.1% | −16.9% |
| Beta (5Y) | 0.96 | 1.09 |
| Employees | 4,100 | 7,071 |
| StockData Score | ||
| Total score | 17 (better) | 12 |
| Valuation score | 3 | 3 |
| Growth score | 4 (better) | 2 |
| Performance score | 3 (better) | 1 |
| Health score | 3 (better) | 2 |
| Dividend score | 4 | 4 |
| Valuation | ||
| P/E | 14.9× (better) | 19.4× |
| P/S | 0.7× | 0.5× (better) |
| P/B | 1.9× | 1.2× (better) |
| EV/EBITDA | 8.3× | 7.1× (better) |
| P/FCF | 10.4× | 9.7× (better) |
| FCF yield | 9.7% | 10.3% (better) |
| Fair value | $58.14 | $21.55 |
| Margin of safety | 18.9% (better) | 11.0% |
| Growth | ||
| Revenue growth (TTM) | 3.0% (better) | 1.3% |
| Revenue growth, 5Y average | 2.7% | 16.6% (better) |
| Net income growth (TTM) | 51.0% | – |
| EPS growth (TTM) | 54.9% | – |
| EPS growth, 5Y average | 33.7% | – |
| Profitability | ||
| Gross margin | 23.2% | 26.6% (better) |
| Operating margin | 7.2% (better) | 6.0% |
| Net margin | 4.7% (better) | 2.4% |
| FCF margin | 6.6% (better) | 4.9% |
| Return on equity | 13.1% (better) | 6.2% |
| Return on invested capital | 9.5% (better) | 6.5% |
| Financial health | ||
| Debt / equity | 0.64 (better) | 0.89 |
| Net debt / EBITDA | 1.93 (better) | 2.87 |
| Interest coverage | 8.3× (better) | 2.2× |
| Current ratio | 1.78 | 2.23 (better) |
| Altman Z-score | 2.88 (better) | 1.89 |
| Piotroski F-score | 6 (better) | 3 |
| Dividends and buybacks | ||
| Dividend yield | 2.3% (better) | 1.7% |
| Payout ratio | 33.3% | 32.1% |
| Years of dividend growth | 14 (better) | 0 |
| Dividend growth, 5Y average | 6.6% (better) | 0.00% |
| Buyback yield | 3.2% (better) | 0.55% |
| Shareholder yield | 5.4% (better) | 2.2% |
| Ownership | ||
| Held by institutions | 93.4% | 102% |
| Held by insiders | 3.0% | 10.1% |
| Insider net buying, 12 months | −$51.5K (better) | −$3.4M |
| Short interest, % of float | 4.2% | 7.1% |
Go deeper
- APOG stock overview
- APOG income statement
- APOG valuation and score
- NX stock overview
- NX income statement
- NX valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.